Neurologic clinical trial - UCB MG0004 OLE

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT04124965

CONDITIONS: Myasthenia gravis, generalized myasthenia gravis - TRIAL: Open Label Extension  for MG0003 Study

Drug

Rozanolixizumab

Phase

Phase 3

Condition

Myasthenia gravis generalized myasthenia gravis

Keywords

Rozanolixizumab | UCB Biopharma SRL